BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 15975538)

  • 1. Hostile bile limits anti-cancer immunity.
    Parathan P; Mielke LA
    Immunity; 2024 Apr; 57(4):834-836. PubMed ID: 38599174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COULD THE INTESTINAL EPITHELIAL ALTERATIONS PROMOTED BY ROUX-EN-Y GASTRIC BYPASS EXPLAIN HIGHER TENDENCY FOR COLONIC DISEASES IN BARIATRIC PATIENTS?
    Wendler E; Malafaia O; Ariede BL; Ribas-Filho JM; Czeczko NG; Nassif PAN
    Arq Bras Cir Dig; 2021; 33(4):e1570. PubMed ID: 33759960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer.
    Cao L; Che Y; Meng T; Deng S; Zhang J; Zhao M; Xu W; Wang D; Pu Z; Wang G; Hao H
    Oncotarget; 2017 Sep; 8(38):63665-63679. PubMed ID: 28969019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The secondary bile acid, deoxycholate accelerates intestinal adenoma-adenocarcinoma sequence in Apc (min/+) mice through enhancing Wnt signaling.
    Cao H; Luo S; Xu M; Zhang Y; Song S; Wang S; Kong X; He N; Cao X; Yan F; Wang B
    Fam Cancer; 2014 Dec; 13(4):563-71. PubMed ID: 25106466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
    Wertheim BC; Smith JW; Fang C; Alberts DS; Lance P; Thompson PA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):197-204. PubMed ID: 22058145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa.
    Johnson IT
    Food Chem Toxicol; 2002 Aug; 40(8):1171-8. PubMed ID: 12067580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic mucosal proliferation is related to serum deoxycholic acid levels.
    Ochsenkühn T; Bayerdörffer E; Meining A; Schinkel M; Thiede C; Nüssler V; Sackmann M; Hatz R; Neubauer A; Paumgartner G
    Cancer; 1999 Apr; 85(8):1664-9. PubMed ID: 10223558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies.
    Bernstein C; Bernstein H; Garewal H; Dinning P; Jabi R; Sampliner RE; McCuskey MK; Panda M; Roe DJ; L'Heureux L; Payne C
    Cancer Res; 1999 May; 59(10):2353-7. PubMed ID: 10344743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.
    Shiraki K; Ito T; Sugimoto K; Fuke H; Inoue T; Miyashita K; Yamanaka T; Suzuki M; Nabeshima K; Nakano T; Takase K
    Int J Mol Med; 2005 Oct; 16(4):729-33. PubMed ID: 16142412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
    Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bile acids, programmed cell death and cell proliferation in the mucosa of patients with colorectal adenomas.
    Fracchia M; Galatola G; Sarotto I; Guraldo V; Perona M; Pera A; Risio M
    Dig Liver Dis; 2005 Jul; 37(7):509-14. PubMed ID: 15975538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bile acids in colorectal carcinogenesis.
    Nagengast FM; Grubben MJ; van Munster IP
    Eur J Cancer; 1995; 31A(7-8):1067-70. PubMed ID: 7576993
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.